Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study-Reference-Cited by-同舟云学术

Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study

Published:2022-12 Issue: Volume:86 Page:104364
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

She Yunlang,He Bingxi,Wang Fang,Zhong Yifan,Wang Tingting,Liu Zhenchuan,Yang Minglei,Yu Bentong,Deng Jiajun,Sun Xiwen^ORCID,Wu Chunyan,Hou Likun,Zhu Yuming,Yang Yang,Hu Hongjie,Dong Di,Chen Chang,Tian Jie

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Chinese Academy of Sciences

Science and Technology Commission of Shanghai Municipality

Natural Science Foundation of Beijing Municipality

Shanghai Hospital Development Center

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference29 articles.

1. Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure;Boyd;J Thorac Oncol,2010

2. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;Lancet,2014

3. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer;Topalian;N Engl J Med,2012

4. Neoadjuvant PD-1 blockade in resectable lung cancer;Forde;N Engl J Med,2018

5. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial;Shu;Lancet Oncol,2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning to estimate response of concurrent chemoradiotherapy in non-small-cell lung carcinoma;2024-09-09

2. Multiregional dynamic contrast-enhanced MRI-based integrated system for predicting pathological complete response of axillary lymph node to neoadjuvant chemotherapy in breast cancer: multicentre study;eBioMedicine;2024-09

3. Deep learning model based on primary tumor to predict lymph node status in clinical stage IA lung adenocarcinoma: a multicenter study;Journal of the National Cancer Center;2024-09

4. Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study;Journal for ImmunoTherapy of Cancer;2024-09

5. Radiogenomics: bridging the gap between imaging and genomics for precision oncology;MedComm;2024-09